MedTrace Logo

Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes Mellitus

NCT02204384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2017-02-14

No results posted yet for this study

Summary

To compare the acute effect of soluble fiber intake from foods or supplement after a common meal on postprandial plasma glucose and insulin in patients with type 2 diabetes. The hypothesis is a meal with a high content of soluble fiber from food determines glycemic and insulinemic response similar to a meal with a high content of soluble fiber from supplement sources.

Conditions

  • Dietary Modification
  • Diabetes Mellitus Type 2
  • Insulin Tolerance
  • Diabetic Blood Glucose Monitoring

Interventions

OTHER

HFD Meal: High fiber from food

High amount of fiber from diet food sources (HFD; total fiber 9.7g; soluble fiber 5.4g)

DIETARY_SUPPLEMENT

HFS Meal: High fiber from supplement

High amount of soluble fiber from guar gum supplement (HFS; total fiber 9.1g; soluble fiber 5.4g) - sachet 5 g Fiber Mais, Nestlé Brasil, São Paulo, BR

OTHER

UF Meal: usual amount of fiber

Usual amount of fiber (UF; total fiber 2.4g; soluble fiber 0.8g)

Sponsors & Collaborators

  • Federal University of Rio Grande do Sul

    collaborator OTHER

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Mirela J Azevedo, PhD · Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-03-31
Completion
2017-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204384 on ClinicalTrials.gov